• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑吡坦对中风、创伤和缺氧所致脑损伤后神经功能障碍疗效的证据综述:进一步临床试验的理由

A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.

作者信息

Sutton J A, Clauss R P

机构信息

a ReGen Therapeutics plc and Guildford Clinical Pharmacology Ltd. , Midhurst , West Sussex , UK.

b Department of Nuclear Medicine , Royal Surrey County Hospital , Guildford , Surrey , UK.

出版信息

Brain Inj. 2017;31(8):1019-1027. doi: 10.1080/02699052.2017.1300836. Epub 2017 May 23.

DOI:10.1080/02699052.2017.1300836
PMID:28534652
Abstract

During 15 years, 23 clinical reports and 6 studies have demonstrated associations between sub-sedative doses of zolpidem and recoveries from brain damage due to strokes, trauma and hypoxia. Clinical findings include unexpected awakenings from vegetative states and regressions of stroke symptoms after dosing that disappear during elimination and reappear on repeat dosing. Initially single-photon emission computed tomography scans showed improved perfusion within, around and distant from infarctions. Then positron emission tomography scans and electroencephalography detected renewed metabolic and neuronal activity. Placebo or a similar, gamma-aminobutyric acid (GABA)-ergic, sedative zopiclone has no such effect. The effect appears only several months after the injury, reflecting recent evidence in mice of substantial differences between the states of GABA receptors in acute and chronic repair phases of recovery. Zolpidem's good safety record and rapid absorption further indicate a need for more clinical trials. List of acronyms: BOLD, Blood-Oxygen-Level Dependent contrast imaging in MRI; CRS, Coma Recovery Scale; CRS-R, Coma Recovery Scale Revised; CSI, Cerebral State Index; CSM, Cerebral State Monitor; DOC, Disorder of Consciousness; EEG, Electro Encephalography; FDG-PET, FluoroDeoxyGlucose-Positron Emission Tomography; FTD, Frontotemporal dementia; GABA, Gamma-Aminobutyric Acid; MCS, Minimally Conscious State; M-EEG, Magneto-Encephalography; MRI, Magnetic Resonance Image; MSN, Median Spiny Neurones; PET, Positron Emission Tomography; PVS, Persistent Vegetative Sate; RLAC, Rancho Los Amigos Cognitive scores; SPECT, Single-photon emission computed tomography; TFES, Tinetti Falls Efficacy Scale; 99mTc HMPAO, Technetium hexamethylpropyleneamine oxime.

摘要

在15年的时间里,23份临床报告和6项研究表明,亚镇静剂量的唑吡坦与中风、创伤和缺氧导致的脑损伤恢复之间存在关联。临床发现包括从植物人状态意外苏醒,以及给药后中风症状的消退,这些症状在药物清除期消失,再次给药时又会出现。最初,单光子发射计算机断层扫描显示梗死灶内部、周围及远处的灌注有所改善。随后,正电子发射断层扫描和脑电图检测到代谢和神经元活动重新出现。安慰剂或类似的、γ-氨基丁酸(GABA)能的镇静剂佐匹克隆没有这种效果。这种效果仅在损伤数月后出现,这反映了最近在小鼠身上的证据,即GABA受体在恢复的急性和慢性修复阶段的状态存在显著差异。唑吡坦良好的安全记录和快速吸收进一步表明需要进行更多的临床试验。缩略词列表:BOLD,磁共振成像中的血氧水平依赖对比成像;CRS,昏迷恢复量表;CRS-R,修订版昏迷恢复量表;CSI,脑状态指数;CSM,脑状态监测仪;DOC,意识障碍;EEG,脑电图;FDG-PET,氟脱氧葡萄糖正电子发射断层扫描;FTD,额颞叶痴呆;GABA,γ-氨基丁酸;MCS,微意识状态;M-EEG,脑磁图;MRI,磁共振成像;MSN,中型多棘神经元;PET,正电子发射断层扫描;PVS,持续性植物状态;RLAC,兰乔洛斯阿米戈斯认知评分;SPECT,单光子发射计算机断层扫描;TFES,Tinetti跌倒效能量表;99mTc HMPAO,锝六甲基丙烯胺肟。

相似文献

1
A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.唑吡坦对中风、创伤和缺氧所致脑损伤后神经功能障碍疗效的证据综述:进一步临床试验的理由
Brain Inj. 2017;31(8):1019-1027. doi: 10.1080/02699052.2017.1300836. Epub 2017 May 23.
2
Clinical and brain SPECT scan response to zolpidem in patients after brain damage.脑损伤患者对唑吡坦的临床及脑单光子发射计算机断层扫描反应
Arzneimittelforschung. 2010;60(4):177-81. doi: 10.1055/s-0031-1296269.
3
Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans.唑吡坦对人脑99mTc HMPAO脑单光子发射计算机断层扫描检测到的脑损伤和交叉性神经机能联系不能的影响。
Arzneimittelforschung. 2004;54(10):641-6. doi: 10.1055/s-0031-1297015.
4
Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications.脑损伤后昏迷患者应用唑吡坦促醒:定量评估及适应证。
Am J Med Sci. 2014 Mar;347(3):178-82. doi: 10.1097/MAJ.0b013e318287c79c.
5
Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report.唑吡坦给药后缺氧性脑损伤相关的最低意识状态短暂逆转:一例报告
Arch Phys Med Rehabil. 2008 Feb;89(2):386-8. doi: 10.1016/j.apmr.2007.08.137.
6
GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report.GABA(A)α-1 亚基介导的去同步化增强低频脑电波活动可减轻卒中特定功能障碍:病例报告
Clin Neurophysiol. 2010 Apr;121(4):549-55. doi: 10.1016/j.clinph.2009.11.084. Epub 2010 Jan 25.
7
Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics.唑吡坦用于持续性植物状态——一项儿科安慰剂对照试验
Neuropediatrics. 2010 Oct;41(5):223-7. doi: 10.1055/s-0030-1269893. Epub 2011 Jan 5.
8
Measures of metabolism and complexity in the brain of patients with disorders of consciousness.意识障碍患者大脑中的代谢与复杂性测量
Neuroimage Clin. 2017 Feb 6;14:354-362. doi: 10.1016/j.nicl.2017.02.002. eCollection 2017.
9
Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.唑吡坦和氟马西尼治疗后狒狒的脑血流灌注情况。
Arzneimittelforschung. 2002;52(10):740-4. doi: 10.1055/s-0031-1299960.
10
Blood-brain barrier integrity in a zolpidem-responder patient.唑吡坦反应者患者的血脑屏障完整性。
S Afr Med J. 2012 Jul 31;102(10):790-1. doi: 10.7196/samj.5993.

引用本文的文献

1
Sleep spindles as a predictor of cognitive motor dissociation and recovery of consciousness after acute brain injury.睡眠纺锤波作为急性脑损伤后认知运动分离和意识恢复的预测指标。
Nat Med. 2025 May;31(5):1578-1585. doi: 10.1038/s41591-025-03578-x. Epub 2025 Mar 3.
2
Differential regulation of K-Cl cotransporter 2 (KCC2) and Na-K-Cl cotransporter 1 (NKCC1) expression by zolpidem in CA1 and CA3 hippocampal subregions of the lithium-pilocarpine status epilepticus rat model.唑吡坦对锂-匹罗卡品癫痫持续状态大鼠模型海马CA1和CA3亚区钾氯共转运体2(KCC2)和钠钾氯共转运体1(NKCC1)表达的差异调节
Exp Anim. 2025 Apr 20;74(2):286-299. doi: 10.1538/expanim.24-0120. Epub 2025 Jan 9.
3
Microwave-assisted protocol towards synthesis of heterocyclic molecules: a comparative analysis with conventional synthetic methodologies (years 2019-2023): a review.
微波辅助合成杂环分子的方法:与传统合成方法的比较分析(2019 - 2023年):综述
Mol Divers. 2025 Jun;29(3):2717-2763. doi: 10.1007/s11030-024-10981-y. Epub 2024 Sep 20.
4
Alleviating sleep disturbances and modulating neuronal activity after ischemia: Evidence for the benefits of zolpidem in stroke recovery.缓解缺血后睡眠障碍和调节神经元活动:唑吡坦在中风康复中的益处证据。
CNS Neurosci Ther. 2024 Feb;30(2):e14637. doi: 10.1111/cns.14637.
5
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.基于证据的共识指南:英国精神药理学协会对紧张症管理的建议。
J Psychopharmacol. 2023 Apr;37(4):327-369. doi: 10.1177/02698811231158232. Epub 2023 Apr 11.
6
2-(4-Fluorophenyl)-1-benzo[]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators.2-(4-氟苯基)-1-苯并咪唑作为开发代谢稳定、α1β2γ2GABA-A 受体正变构调节剂的有前途的模板。
ACS Chem Neurosci. 2023 Mar 15;14(6):1166-1180. doi: 10.1021/acschemneuro.2c00800. Epub 2023 Feb 27.
7
Cortical and thalamic connections of the human globus pallidus: Implications for disorders of consciousness.人类苍白球的皮质和丘脑连接:对意识障碍的启示。
Front Neuroanat. 2022 Aug 25;16:960439. doi: 10.3389/fnana.2022.960439. eCollection 2022.
8
Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease.新型获批及在研药物治疗帕金森病的运动症状。
Drugs. 2022 Jul;82(10):1027-1053. doi: 10.1007/s40265-022-01747-7. Epub 2022 Jul 16.
9
Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.脑外伤后意识障碍的临床决策:向前迈进。
Neurosci Bull. 2023 Jan;39(1):138-162. doi: 10.1007/s12264-022-00909-7. Epub 2022 Jul 8.
10
Whole-brain modelling identifies distinct but convergent paths to unconsciousness in anaesthesia and disorders of consciousness.全脑建模确定了麻醉和意识障碍中通向无意识的不同但趋同的途径。
Commun Biol. 2022 Apr 20;5(1):384. doi: 10.1038/s42003-022-03330-y.